D. Carbone

D. Carbone's research centers on lung cancer, particularly non-small cell lung cancer (NSCLC) and small cell lung cancer, with a focus on immunotherapy, chemotherapy, and biomarkers that can predict treatment response or side effects. Work includes clinical trials testing new drug combinations and molecular tools like plasma proteomics (blood protein profiling) to guide treatment decisions. This research is clinically oriented, often involving multi-site trial data reported at oncology conferences and in specialty journals.

Publication output has been low and irregular over the past decade, with intermittent years of activity (typically 2 publications) interspersed with years of no recorded output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026